[Erythropoietic protoporphyria (II. Pathogenesis, physiopathology and treatment)].
D000249:Adenosine Monophosphate / Q000627:therapeutic use; D000255:Adenosine Triphosphate / Q000627:therapeutic use; D000962:Antimalarials / Q000627:therapeutic use; D004035:Diet Therapy; D004920:Erythropoiesis; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007288:Inosine / Q000627:therapeutic use; D007538:Isoniazid / Q000627:therapeutic use; D008099:Liver / Q000503:physiopathology; D008110:Liver Extracts / Q000627:therapeutic use; D009824:Ointments; D011164:Porphyrias / Q000188:drug therapy / Q000209:etiology / Q000235:genetics* / Q000503:physiopathology / Q000628:therapy; D013154:Spleen / Q000503:physiopathology; D013156:Splenectomy; D013473:Sunscreening Agents / Q000627:therapeutic use; D014810:Vitamin E / Q000627:therapeutic use
D000962:Antimalarials; D005938:Glucocorticoids; D008110:Liver Extracts; D009824:Ointments; D013473:Sunscreening Agents; D014810:Vitamin E; D000249:Adenosine Monophosphate; D007288:Inosine; D000255:Adenosine Triphosphate; D007538:Isoniazid; D006854:Hydrocortisone
Protoporfira eritropoyética (II. Patogenia, fisiopatología y tratamiento.